Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company based in Canton, MA, specializing in the development, manufacturing, and marketing of a wide range of injectable, intranasal, and inhalation products. Their portfolio includes complex medications derived from living cells or organisms, proteins, and interchangeable biosimilars, as well as innovative drug delivery systems for various routes of administration.
With a focus on providing effective solutions for medical conditions, Amphastar offers proprietary products and technological platforms such as BAQSIMI, the number one prescribed glucagon in the US, which is the first and only dry nasal spray for treating very low blood sugar. They also produce Primatene MIST, the first and only generic epinephrine inhalation aerosol, along with other essential products like glucagon emergency kits and diluents for glucagon injections.
Generated from the website